B43.8 Other forms of chromomycosis

Name of the Condition

• Other forms of chromomycosis
• ICD-10-CM Code B43.8

Summary

Other forms of chromomycosis represent a group of rare fungal infections caused by dematiaceous fungi, affecting tissues beyond the skin and subcutaneous layers. These infections are characterized by chronic, localized involvement that may include deeper structures or specific organ systems. The condition progresses slowly and can persist for extended periods without treatment, potentially leading to tissue damage or systemic spread.

Causes

The infections are caused by dematiaceous (pigmented) fungi, which are found in soil, decaying vegetation, or organic matter. These fungi enter the body through minor trauma, inhalation, or direct inoculation, establishing chronic infections in various tissues. The specific fungal species and route of entry determine the affected anatomical sites.

Risk Factors

• Occupational or recreational exposure to soil, wood, or decaying organic material.
• Immunocompromised status, including conditions like HIV/AIDS or immunosuppressive therapy.
• Living in or traveling to tropical or subtropical regions where these fungi are endemic.
• Minor skin injuries or breaks that allow fungal entry.
• Prior fungal infections or systemic dissemination of dematiaceous fungi.

Symptoms

• Chronic, localized lesions or masses in affected tissues.
• Pain or discomfort in the involved area.
• Discoloration or pigmentation of affected tissues.
• Possible systemic symptoms if infection spreads.
• Functional impairment depending on the affected organ or structure.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Clinical assessment identifies characteristic lesions or symptoms. Imaging (e.g., MRI, CT) may reveal tissue involvement or abscess formation. Laboratory confirmation includes fungal culture, histopathology, or molecular testing to identify dematiaceous fungi. Biopsy of affected tissue is often necessary to confirm the diagnosis.

Treatment Options

Treatment typically includes antifungal medications, such as itraconazole or terbinafine, tailored to the specific fungal species and infection severity. Surgical intervention may be required to remove abscesses or necrotic tissue. Long-term therapy is often necessary to prevent recurrence, and immunocompromised patients may need extended treatment durations.

Prognosis and Follow-Up

Prognosis depends on the extent of infection, underlying health status, and timeliness of treatment. Early intervention improves outcomes, but chronic or widespread infections may have a guarded prognosis. Regular follow-up is essential to monitor for recurrence, treatment response, or complications. Immunocompromised patients require closer surveillance.

Complications

• Tissue damage or scarring from chronic infection.
• Spread to other organs or systemic dissemination.
• Secondary bacterial infections.
• Functional impairment due to affected tissues or organs.
• Delayed diagnosis leading to advanced disease.

Lifestyle & Prevention

• Avoid contact with soil or decaying organic matter, especially in endemic regions.
• Wear protective clothing (e.g., gloves, boots) during outdoor activities.
• Clean and treat minor skin injuries promptly to prevent fungal entry.
• Maintain good overall health to support immune function.
• Seek medical attention for persistent or worsening skin lesions.

When to Seek Professional Help

Consult a healthcare provider if you experience:

• Persistent or worsening skin lesions that do not heal.
• Unexplained masses or discoloration in tissues.
• Symptoms of systemic infection (e.g., fever, fatigue).
• Exposure to soil or organic matter followed by skin trauma.
• Immunosuppression with new or unusual symptoms.

Tips for Medical Coders

When coding for B43.8 (Other forms of chromomycosis), ensure documentation specifies the anatomical site or tissue involvement (e.g., lymphatic, visceral) to support the code assignment. Verify that the diagnosis aligns with clinical findings and laboratory confirmation of dematiaceous fungi. Document the extent of infection and any associated complications to accurately reflect the condition.